ARCHIVES

ODAC To Advise FDA on First Biosimilars Application Jan. 7

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Pittsburgh Broadens Misconduct Inquiry

June 3, 1994

Sirolimus-Containing Therapy Reduces GVHD, Study Finds

January 31, 2003

In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR

April 27, 1979

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

In Brief: Upton Says Delaney Clause Is Needed: CPSC Drops Effort To Set Policy On Carcinogens

May 4, 1979

Stop Cancer Still Working To Raise Funds

March 22, 1991